Cargando…
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
The major human liver drug metabolising cytochrome P450 (CYP) enzymes are downregulated during inflammation and infectious disease state, especially during coronavirus disease 2019 (COVID-19) infection. The influx of proinflammatory cytokines, known as a ‘cytokine storm’, during severe COVID-19 lead...
Autores principales: | Lim, Sharoen Yu Ming, Al Bishtawi, Basel, Lim, Willone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123480/ https://www.ncbi.nlm.nih.gov/pubmed/37093458 http://dx.doi.org/10.1007/s13318-023-00826-8 |
Ejemplares similares
-
Protein-Ligand Identification and In Vitro Inhibitory Effects of Cathine on 11 Major Human Drug Metabolizing Cytochrome P450s
por: Lim, Sharoen Y. M., et al.
Publicado: (2022) -
Current state and future perspectives of cytochrome P450 enzymes for C–H and C=C oxygenation
por: Yan, Yu, et al.
Publicado: (2022) -
Human cytochromes P450: evolution and cDNA-directed expression.
por: Gonzalez, F J, et al.
Publicado: (1992) -
Epoxidation Activities of Human Cytochromes P450c17
and P450c21
por: Yoshimoto, Francis K., et al.
Publicado: (2014) -
Structure and Dynamics of the Membrane-Bound Cytochrome P450 2C9
por: Cojocaru, Vlad, et al.
Publicado: (2011)